- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.06. | AbbVie climbs post-Allergan M&A peak with Apogee buy | ||
| 22.06. | Boehringer advances duo for aggressive cancers into phase 3 | ||
| 22.06. | Genpact finds $18tn in trapped AI value | ||
| 22.06. | Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance | ||
| 22.06. | Sanofi names ex-Roche exec Fontoura as R&D chief | ||
| 19.06. | US launches probe of German 'underpayment' for medicines | ||
| 19.06. | Which biotechs have raised new VC financing this week? | ||
| 19.06. | FDA experts endorse Moderna's mRNA seasonal flu shot | ||
| 18.06. | MSD takes on Pfizer's Prevnar with new Capvaxive approval | ||
| 18.06. | FDA approves first generic of Roche's flu drug Xofluza | ||
| 18.06. | Heart drug biotech Kardigan raises $400m in upscaled IPO | ||
| 18.06. | UK will be first market for Sanofi's subcutaneous Sarclisa | ||
| 18.06. | GSK claims FDA okay for first oral carbapenem antibiotic | ||
| 18.06. | AI agents can beat doctors in clinical decision-making | ||
| 18.06. | Biogen pens $1bn deal to buy immunology biotech RayThera | ||
| 17.06. | uniQure sets course to US filing for Huntington gene therapy | ||
| 17.06. | Jazz orchestrates a $4bn cancer alliance with AbCellera | ||
| 17.06. | MSD steps out with Protillion in $510m+ AI shindig | ||
| 17.06. | Moderna builds commercial muscle as new launches loom | ||
| 17.06. | Hacking ring seeks to extort Novo Nordisk after cyberattack | ||
| 16.06. | Germany said to be backtracking on pharma rebate changes | ||
| 16.06. | German said to be backtracking on pharma rebate changes | ||
| 16.06. | FDA starts kicks off review of Gilead's weekly HIV pill | ||
| 16.06. | Dispensing data exposes health inequalities in England | ||
| 16.06. | Poolbeg expects first data for CRS drug in the summer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.